CLINICAL_TRIALS trial_result · 2019-12-24

Clinical Trial Update: Ponatinib in Advanced NSCLC w/ RET Translocations [Phase 2]

Phase 2 trial of ponatinib in advanced non-small cell lung cancer with RET translocations has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Massachusetts General Hospital | Conditions: Non Small Cell Lung Cancer | Phase 2 | Status: COMPLETED | Results posted: 2019-12-24